- (a) Specifications. Each milliliter (mL) of suspension contains 6 milligrams (mg) betamethasone (3.15 mg betamethasone sodium phosphate and 2.85 mg betamethasone acetate).
- (b) Sponsor. See No. 010797 in § 510.600(c) of this chapter.
- (c) Conditions of use in horses—(1) Amount. Administer 1.5 mL (9 mg total betamethasone) per joint by intra-articular injection. May be administered concurrently in up to two joints per horse.
- (2) Indications for use. For the control of pain and inflammation associated with osteoarthritis in horses.
- (3) Limitations. Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[80 FR 18776, Apr. 8, 2015]